Daniel Ghinn, Author at

With studies showing potential for SGLT2 inhibitors in heart failure, a study of HCP online conversations reveals cardiologists

SGLT2 inhibitors: an emerging option for cardiologists?

https://pharmaphorum.com/views-and-analysis/sglt2-inhibitors-cardiologists-option/

NICE is reaching out and engaging more via social media.

How healthcare professionals engage NICE online

https://pharmaphorum.com/views-and-analysis/healthcare-professionals-engage-nice-online/

A year after Zika virus was confirmed in the Americas, Daniel Ghinn reviews HCP reactions on social media.

What doctors say about Zika virus

https://pharmaphorum.com/transversal-categories/digital-and-social-media/what-doctors-say-about-zika-virus/

About Daniel Ghinn